Memantine hydrochloride
Memantine Hydrochloride is a generic prescription medication available as oral tablets in 5 mg and 10 mg strengths. It acts as an NMDA receptor antagonist and is used to treat symptoms of moderate to severe Alzheimer's disease. Manufactured by Carlsbad Technology, Inc., under ANDA 212947. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Memantine Hydrochloride is a generic prescription medication available as oral tablets in 5 mg and 10 mg strengths. It acts as an NMDA receptor antagonist and is used to treat symptoms of moderate to severe Alzheimer's disease. Manufactured by Carlsbad Technology, Inc., under ANDA 212947. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Memantine hydrochloride",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Memantine hydrochloride — ANDA 206310 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206310"
}
]
|
| identifier | ANDA206310 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"health-care",
"medications"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Memantine hydrochloride |
